Abbas Salihi

Prof. Abbas Salihi

Salahaddin University-Erbil, Erbil, Arbīl, Iraq
orcid
Ph.D, Assistant Professor of Molecular Physiology

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
MFMojtaba Falahati
Mojtaba Falahati
FAFarnoosh Attar
Farnoosh Attar
Majid SharifiMajid Sharifi
Majid Sharifi
ASAli Akbar Saboury
Ali Akbar Saboury
Abbas SalihiAbbas Salihi
Abbas Salihi
MEMostafa A. El-Sayed
Mostafa A. El-Sayed

17 July 2023 in Military Medical Research
Verified
Journal Article
Open access
PDF file
BMBashdar Mahmud
Bashdar Mahmud
MRMohammed Fatih Rasul
Mohammed Fatih Rasul
SASnur Rasool Abdullah
Snur Rasool Abdullah
HHHazha Jamal Hidayat
Hazha Jamal Hidayat
GFGoran Sedeeq Hama Faraj
Goran Sedeeq Hama Faraj
Mohammad TaheriMohammad Taheri
Mohammad Taheri
Clustered regulatory interspaced short palindromic repeats (CRISPR) has changed biomedical research and provided entirely new models to analyze every aspect of biomedical sciences during the last decade. In the study of cancer, the CRISPR/CRISPR-associated protein (Cas) system opens new avenues into issues that were once unknown in our knowledge of the noncoding genome, tumor heterogeneity, and precision medicines. CRISPR/Cas-based gene-editing technology now allows for the precise and permanent targeting of mutations and provides an opportunity to target small non-coding RNAs such as microRNAs (miRNAs). However, the development of effective and safe cancer gene editing therapy is highly dependent on proper design to be innocuous to normal cells and prevent introducing other abnormalities. This study aims to highlight the cutting-edge approaches in cancer-gene editing therapy based on the CRISPR/Cas technology to target miRNAs in cancer therapy. Furthermore, we highlight the potential challenges in CRISPR/Cas-mediated miRNA gene editing and offer advanced strategies to overcome them.

1 August 2019 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
ZZZahra Zand
Zahra Zand
PKPegah Afarinesh Khaki
Pegah Afarinesh Khaki
Abbas SalihiAbbas Salihi
Abbas Salihi
Majid SharifiMajid Sharifi
Majid Sharifi
NNNadir Mustafa Qadir Nanakali
Nadir Mustafa Qadir Nanakali
MFMojtaba Falahati
Mojtaba Falahati
Aim: Among therapeutic proposals for amyloid-associated disorders, special attention has been given to the exploitation of nanoparticles (NPs) as promising agents against aggregation. Methods: In this paper, the inhibitory effect of cerium oxide (CeO2) NPs against α-synuclein (α-syn) amyloid formation was explored by different methods such as Thioflavin T (ThT) and 8-anilinonaphthalene-1-sulfonic acid (ANS) fluorescence spectroscopy, Congo red adsorption assay, circular dichroism (CD) spectroscopy, transmission electron microscopy (TEM), and bioinformatical approaches. Also, the cytotoxicity of α-syn amyloid either alone or with CeO2 NPs against neuron-like cells (SH-SY5Y) was examined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), flow cytometry, and quantitative real-time polymerase chain reaction (Bax and Bcl-2 gene expression) assays. Results: ThT and ANS fluorescence assays indicated that CeO2 NPs inhibit the formation of aggregated species and hydrophobic patches of α-syn in amyloidogenic conditions, respectively. Congo red and CD assays demonstrated that CeO2 NPs reduce the formation of amyloid species and β-sheets structures of α-syn molecules, respectively. TEM investigation also confirmed that CeO2 NPs limited the formation of well-defined fibrillary structures of α-syn molecules. Molecular docking and dynamic studies revealed that CeO2 NPs could bind with different affinities to α-syn monomer and amyloid species and fibrillar structure of α-syn is disaggregated in the presence of CeO2 NPs. Moreover, cellular assays depicted that CeO2 NPs mitigate the cell mortality, apoptosis, and the ratio of Bax/Bcl-2 gene expression associated with α-syn amyloids. Conclusion: It may be concluded that CeO2 NPs can be used as therapeutic agents to reduce the aggregation of proteins and mitigate the occurrence of neurodegenerative diseases.

1 February 2022 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
KMKarwan M-Amen
Karwan M-Amen
OAOmiad S Abdullah
Omiad S Abdullah
AAAhmed M.S Amin
Ahmed M.S Amin
ZMZeki Ali Mohamed
Zeki Ali Mohamed
BHBestoon Hasan
Bestoon Hasan
Abbas SalihiAbbas Salihi
Abbas Salihi
Introduction: There are limited published data regarding the recent incidence trends of cancer in Iraqi Kurdistan. Methods: The present study assessed the epidemiological estimates of cancer incidence, as well providing a projection of future cancer trends in the upcoming decade by analysing the population-based cancer registry between 2013 and 2019, in both the Erbil and Duhok governorates. A retrospective analysis was performed on data retrieved from the Medical Statistics Department at the Ministry of Health, Kurdistan Regional Government (KRG). Results: The total number of female cancer patients was higher in both governorates, and the total incidence of patients with cancer increased by over 2x between 2013 and 2019 in Erbil and Duhok, from 73 to 174 patients/100,000 individuals for women, and 36 to 85 patients/100,000 individuals for men. Analysis indicated that the percentage of patients with cancer is projected to increase by >2x in the current decade, from 3,457 cases to 4,547 and 4,449 cases in the Erbil governorate; and from 1,365 to 2,633 and 2,737 cases in 2028 based on LSTM and bi-LTSM analysis in the Duhok governorate. Lung cancer (LC) and female breast cancer (BC) were the most prominent types of cancers diagnosed since 2013 in both the Erbil and Duhok governorates. Conclusion: The striking pattern of trends for both present and future cancer incidence rates require urgent solutions and comprehensive efforts to control risk factors that promote the increasing incidence of cancer in these two KRG governorates.

1 June 2019 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
SGSeyedeh Sahar Tahaei Gilan
Seyedeh Sahar Tahaei Gilan
DRDorsa Yahya Rayat
Dorsa Yahya Rayat
TMTwana Ahmed Mustafa
Twana Ahmed Mustafa
FAFalah Mohammad Aziz
Falah Mohammad Aziz
KSKoorosh Shahpasand
Koorosh Shahpasand
MFMojtaba Falahati
Mojtaba Falahati
Aim: It has been indicated that NPs may change the amyloidogenic steps of proteins and relevant cytotoxicity. Therefore, this report assigned to explore the impact of ZVFe NPs on the amyloidogenicity and cytotoxicity of α-synuclein as one of the many known amyloid proteins. Methods: The characterization of α-synuclein at amyloidogenic condition either alone or with ZVFe NPs was carried out by fluorescence, CD, UV-visible spectroscopic methods, TEM study, docking, and molecular modeling. The cytotoxicity assay of α-synuclein amyloid in the absence and presence of ZVFe NPs was also done by MTT, LDH, and flow cytometry analysis. Results: ThT fluorescence spectroscopy revealed that ZVFe NPs shorten the lag phase and accelerate the fibrillation rate of α-synuclein. Nile red and intrinsic fluorescence spectroscopy, CD, Congo red adsorption, and TEM studies indicated that ZVFe NP increased the propensity of α-synuclein into the amyloid fibrillation. Molecular docking study revealed that hydrophilic residues, such as Ser-9 and Lys-12 provide proper sites for hydrogen bonding and electrostatic interactions with adsorbed water molecules on ZVFe NPs, respectively. Molecular dynamics study determined that the interacted protein shifted from a natively discorded conformation toward a more packed structure. Cellular assay displayed that the cytotoxicity of α-synuclein amyloid against SH-SY5Y cells in the presence of ZVFe NPs is greater than the results obtained without ZVFe NPs. Conclusion: In conclusion, the existence of ZVFe NPs promotes α-synuclein fibrillation at amyloidogenic conditions by forming a potential template for nucleation, the growth of α-synuclein fibrillation and induced cytotoxicity.

22 July 2019 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
Majid SharifiMajid Sharifi
Majid Sharifi
AKAbdulkarim Yasin Karim
Abdulkarim Yasin Karim
NNNadir Mustafa Qadir Nanakali
Nadir Mustafa Qadir Nanakali
Abbas SalihiAbbas Salihi
Abbas Salihi
FAFalah Mohammad Aziz
Falah Mohammad Aziz
MFMojtaba Falahati
Mojtaba Falahati
Enzymes are one of the foundations and regulators for all major biological activities in living bodies. Hence, enormous efforts have been made for enhancing the efficiency of enzymes under different conditions. The use of nanomaterials as novel carriers for enzyme delivery and regulating the activities of enzymes has stimulated significant interests in the field of nano-biotechnology for biomedical applications. Since, all types of nanoparticles (NPs) offer large surface to volume ratios, the use of NPs as enzyme carriers affect the structure, performance, loading efficiency, and the reaction kinetics of enzymes. Hence, the immobilization of enzymes on nanomatrices can be used as a useful approach for direct delivery of therapeutic enzymes to the targeted sites. In other words, NPs can be used as advanced enzyme delivery nanocarriers. In this paper, we present an overview of different binding of enzymes to the nanomaterials as well as different types of nanomatrix supports for immobilization of enzymes. Afterwards, the enzyme immobilization on nanomaterials as a potential system for enzyme delivery has been discussed. Finally, the challenges associated with the enzyme delivery using nano matrices and their future perspective have been discussed. Communicated by Ramasamy H. Sarma